Pacira BioSciences
PCRX
214 hedge funds and large institutions have $3.29B invested in Pacira BioSciences in 2015 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 70 increasing their positions, 66 reducing their positions, and 23 closing their positions.
170% more first-time investments, than exits
New positions opened: 62 | Existing positions closed: 23
120% more funds holding in top 10
Funds holding in top 10: 5 → 11 (+6)
87% more capital invested
Capital invested by funds: $1.76B → $3.29B (+$1.53B)
21% more funds holding
Funds holding: 177 → 214 (+37)
6% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 66
39% less call options, than puts
Call options by funds: $29M | Put options by funds: $47.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$53.1M |
| 2 |
CCI
Columbus Circle Investors
|
+$41.8M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$32.3M |
| 4 |
FAM
Fred Alger Management
New York
|
+$32.2M |
| 5 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$26.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$52.9M |
| 2 |
MCM
Marsico Capital Management
Denver,
Colorado
|
-$50.4M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
-$40.7M |
| 4 |
VAM
Visium Asset Management
New York
|
-$37.4M |
| 5 |
Goldman Sachs
New York
|
-$27.7M |
PCRX Hedge Fund Activity: Q4 2015 in Review
214 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q4 2015, worth a combined $3.29B — up 87% from $1.76B a quarter earlier.
Buyers outnumbered sellers: 62 funds opened new PCRX positions and 23 closed out — a net gain of 39 holders — while 70 added to existing stakes and 66 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $53.1M. The largest seller was Ameriprise, cutting an estimated $52.9M.
- 214 institutional investors held Pacira BioSciences (PCRX) as of Q4 2015, up from 177 in Q3 2015.
- Funds reported $3.29B of Pacira BioSciences stock for Q4 2015, up 87% quarter-over-quarter.
- 62 funds opened new Pacira BioSciences positions in Q4 2015 and 23 closed out, a net change of +39 holders.
- The largest Pacira BioSciences buyer in Q4 2015 was Fidelity Investments, an estimated $53.1M added.
- The largest Pacira BioSciences seller in Q4 2015 was Ameriprise, an estimated $52.9M sold.
Based on aggregated 13F filings for Q4 2015.